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for 21 years, and hepatitis C, pre-
sented with three bouts of rotatory 
vertigo, emesis and left hearing 
loss. She was on antiretroviral 
treatment since 1992, and, since 
2000 specifically on nevirapine, 
 lamivudine, and zidovudine. Her 
CD4 count and HIV viral load were 
616 cells/mm3 and undetectable, 
respectively. Suspecting Ménière’s 
disease, she was placed on a one-
week treatment of prednisone 
40 mg daily. Two weeks later, a 
fourth attack of vertigo motivated 
another ENT examination reveal-
ing complete deafness on the left, 
sensorineural deafness of 50 dB on 
the right side and bilateral vestibu-
lar dysfunction. A brain MRI 
showed bilateral enhancement of 
the cochlea, semicircular canals 
and vestibulocochlear nerve 
(Fig. 1 a2). Valacyclovir 500 mg tid 
and prednisone 60 mg daily were 
prescribed for putative herpetic 
 infection. Five days later, the pa-
tient was diagnosed with bilateral 
iritis, acute on the left and healing 
on the right eye, which was suc-
cessfully treated with daily topical 
glucocorticoid eye drops. Other-
wise, the patient was afebrile and in 
good general condition.
In August 2006, her CD4 count 
was 128 cells/mm3, a drop that was 
attributed to corticosteroids, but 
HIV viral load remained undetect-
able. A neurological examination 
revealed a horizontal nystagmus 
beating to the right side after sup-
pression of fixation, a positive head 
thrust sign to the left, and ataxia of 
vestibular origin. Audiometry, 
 auditory evoked potentials and 
 caloric testing confirmed the pres-
ence of a bilateral total deafness 
and left vestibular loss. CSF exami-
nation was normal besides proteins 
at 82.5 mg/dl. In the CSF, cultures 
were negative such as were serol-
ogy for syphilis and PCR for HIV, 
cytomegalovirus (CMV), herpes 
simplex-1 and -2, varicella zoster, 
and Epstein-Barr viruses, and for 
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Sirs: Cogan syndrome is an un-
common disease, characterized by 
non-syphilitic interstitial keratitis, 
and cochleovestibular manifesta-
tions. The latter look alike severe 
Ménière’s disease and usually lead 
to deafness in 3 months [1, 2]. 
 Almost 60 % of the patients de-
velop systemic manifestations, 10 % 
of them suffering from life-threat-
ening complications such as a sys-
temic necrotizing vasculitis [3, 4]. 
The physiopathogenesis of Cogan 
syndrome is likely autoimmune, 
possibly mediated by the humoral 
immune response [4, 5].
In July 2006, a 43 year-old 
woman known for HIV infection 
Mycobacterium tuberculosis. Blood 
serologies were negative for syphi-
lis, borreliosis, rubella, mumps and 
the above-mentioned viruses 
 except for slightly positive CMV-
specific IgM and IgG. Except for 
lymphopenia, slightly elevated 
erythrocyte sedimentation rate and 
liver enzymes, an extensive work-
up was within normal limits, in-
cluding neutrophil count, CRP, 
 antinuclear, anti-nucleoproteins, 
and anti-neutrophil cytoplasmic 
antibodies, cryoglobulins, rheuma-
toid factor, angiotensin-converting 
enzyme, HLA-B27, Bence Jones 
proteins in the urine, thoraco-
 abdominal CT scan and transtho-
racic echocardiography. Suspecting 
Cogan syndrome, IV methylpred-
nisolone at 1000 mg/d for 5 days 
followed by slow tapering of pred-
nisone together with mycopheno-
late mofetil 1500 mg/d were intro-
duced. In September, an interstitial 
keratitis of the left eye (Fig. 1 b, c), 
then of the right eye confirmed this 
diagnosis. Ocular lesions re-
sponded favourably to topical 
 steroid therapy; however, the severe 
cochleovestibular deficits did not 
improve at all. In October 2006, 
CD4 count had increased to 599 
cells/mm3.
■ Comment
This is the first description of 
 Cogan’s syndrome in an HIV+ 
 patient. This syndrome was likely 
not due to immunosuppression – 
since CD4 count was high at dis-
ease onset – or to an “immune 
 reconstitution inflammatory syn-
drome” (IRIS) since our patient 
had been on antiretroviral therapy 
for 14 years with a stable CD4 
count. Even if we cannot rule out a 
coincidence, HIV might still have 
been instrumental in the pathogen-
esis of this Cogan syndrome. 
 Indeed, HIV frequently causes an 
autoimmune dysregulation with 
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Fig. 1  a1, a2 Magnetic resonance imaging of the brain. Coronal T1-weighted image showing contrast enhance-
ment of bilateral cochlea (white arrows, a1) and vestibular nerves (white arrows, a2), predominantly on the left 
side. Photograph of the left eye demonstrating typical features of interstitial keratitis: b diffuse corneal haze, c 
central midstromal haze revealed by slit-lamp examination
loss of self-tolerance and increased 
autoimmunity [6, 7].
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